September 18, 2012
Prize4Life, a non-profit organization dedicated to accelerating the discovery of treatments and a cure for Amyotrophic Lateral Sclerosis (ALS), is pleased to congratulate Dr. Tom Maniatis on the recent announcement that he will be receiving a 2012 Special Achievement Award in Medical Science from the Lasker Foundation. Maniatis serves as a member of Prize4Life’s Scientific Advisory Board, a post he has held since the organization was founded in 2006.
“I am so grateful to Tom Maniatis not only for his fierce intellect but also for his unwavering support since Prize4Life’s founding. He has been a valuable member of the Scientific Advisory Board and his expertise and continued commitment to accelerating ALS research have been integral to the successes our organization has enjoyed over the past six years, most notably the awarding of our $1M ALS Biomarker Prize,” said Avi Kremer, Prize4Life’s CEO and co-founder. “We are proud to extend our congratulations to Dr. Maniatis, for his receipt of the Lasker Foundation’s Special Achievement Award.”
Through years of pioneering work, Dr. Maniatis has made multiple discoveries in the fields of gene regulation and expression, molecular cloning, and biotechnology, which have contributed to the development of treatments for multiple genetic disorders. Dr. Maniatis has held positions at Columbia University, Harvard University, The Cold Spring Harbor Laboratory, and the California Institute of Technology. His academic research has been recognized by numerous awards, including the Eli Lilly Research Award in Microbiology and Immunology and the Scientific Achievement Award from the American Medical Association.
In recent years, Dr. Maniatis’ laboratory has focused on ALS and has made significant contributions to ALS research, including his recent work with pluripotent stem cells derived from ALS patients. The Lasker-Koshland Special Achievement Award in Medical Science is awarded for exceptional leadership and citizenship in biomedical science, which it defines in part as having made fundamental discoveries concerning the nature of genes and by disseminating revolutionary technologies to the scientific community. Through his pioneering breakthroughs in multiple branches of medical research, and his willingness to share his knowledge with laboratories and researchers around the world, Dr. Maniatis is an exemplary candidate to receive this honor.
Prize4Life is a nonprofit organization dedicated to accelerating the discovery of treatments and a cure for ALS by using powerful incentives to attract new people and drive innovation. Prize4Life was founded in 2006 by Avi Kremer, who was diagnosed with ALS at the age of 29 while attending Harvard Business School. The organization aims to use prizes to bring new minds and new money into the fight against ALS and focus efforts on specific outcomes that will bridge the gap between academic research and the development of treatments and a cure.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/9/prweb9912372.htm